Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal

This study investigated the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) immunoglobulin G (IgG) during the first pandemic wave in Senegal. The seroprevalence rate of SARS-CoV-2 IgG was assessed in 10 cities in Senegal by testing plasma from volunteers attending heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahouidi, Ambroise D., Anderson, Mark, Diédhiou, Cyrille K., Dia, Aminata, Mbow, Moustapha, Dia, Yacine, Mboup, Aminata, Gaye, Astou Gueye, Manga, Noel M., Cloherty, Gavin, Mboup, Souleymane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Coronavirus (COVID-19) Collection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702669/
https://www.ncbi.nlm.nih.gov/pubmed/35721431
http://dx.doi.org/10.1016/j.ijregi.2021.12.008
_version_ 1784621290817060864
author Ahouidi, Ambroise D.
Anderson, Mark
Diédhiou, Cyrille K.
Dia, Aminata
Mbow, Moustapha
Dia, Yacine
Mboup, Aminata
Gaye, Astou Gueye
Manga, Noel M.
Cloherty, Gavin
Mboup, Souleymane
author_facet Ahouidi, Ambroise D.
Anderson, Mark
Diédhiou, Cyrille K.
Dia, Aminata
Mbow, Moustapha
Dia, Yacine
Mboup, Aminata
Gaye, Astou Gueye
Manga, Noel M.
Cloherty, Gavin
Mboup, Souleymane
author_sort Ahouidi, Ambroise D.
collection PubMed
description This study investigated the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) immunoglobulin G (IgG) during the first pandemic wave in Senegal. The seroprevalence rate of SARS-CoV-2 IgG was assessed in 10 cities in Senegal by testing plasma from volunteers attending healthcare clinics for reasons unrelated to coronavirus disease 2019 (n=3231) between June and October 2020. The overall positivity rate was 20.4% and large geographical differences in seropositivity (6–41.9%) were observed, suggesting that the true number of infections was substantially higher than the official estimate of 8.5%.
format Online
Article
Text
id pubmed-8702669
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87026692021-12-28 Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal Ahouidi, Ambroise D. Anderson, Mark Diédhiou, Cyrille K. Dia, Aminata Mbow, Moustapha Dia, Yacine Mboup, Aminata Gaye, Astou Gueye Manga, Noel M. Cloherty, Gavin Mboup, Souleymane IJID Reg Coronavirus (COVID-19) Collection This study investigated the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) immunoglobulin G (IgG) during the first pandemic wave in Senegal. The seroprevalence rate of SARS-CoV-2 IgG was assessed in 10 cities in Senegal by testing plasma from volunteers attending healthcare clinics for reasons unrelated to coronavirus disease 2019 (n=3231) between June and October 2020. The overall positivity rate was 20.4% and large geographical differences in seropositivity (6–41.9%) were observed, suggesting that the true number of infections was substantially higher than the official estimate of 8.5%. Elsevier 2021-12-24 /pmc/articles/PMC8702669/ /pubmed/35721431 http://dx.doi.org/10.1016/j.ijregi.2021.12.008 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Coronavirus (COVID-19) Collection
Ahouidi, Ambroise D.
Anderson, Mark
Diédhiou, Cyrille K.
Dia, Aminata
Mbow, Moustapha
Dia, Yacine
Mboup, Aminata
Gaye, Astou Gueye
Manga, Noel M.
Cloherty, Gavin
Mboup, Souleymane
Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal
title Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal
title_full Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal
title_fullStr Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal
title_full_unstemmed Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal
title_short Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal
title_sort seroprevalence of sars-cov-2 igg antibodies in a healthcare setting during the first pandemic wave in senegal
topic Coronavirus (COVID-19) Collection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702669/
https://www.ncbi.nlm.nih.gov/pubmed/35721431
http://dx.doi.org/10.1016/j.ijregi.2021.12.008
work_keys_str_mv AT ahouidiambroised seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal
AT andersonmark seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal
AT diedhioucyrillek seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal
AT diaaminata seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal
AT mbowmoustapha seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal
AT diayacine seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal
AT mboupaminata seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal
AT gayeastougueye seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal
AT manganoelm seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal
AT clohertygavin seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal
AT mboupsouleymane seroprevalenceofsarscov2iggantibodiesinahealthcaresettingduringthefirstpandemicwaveinsenegal

Ejemplares similares